ask="19.50"
ask_size="500"
average_daily_volume="159876"
bid="N/A"
bid_size="N/A"
book_value="6.55"
change="+0.07"
change_from_200_day_moving_average="0.44"
change_from_50_day_moving_average="-0.69"
change_from_52_week_high="-3.56"
change_From_52_week_low="3.92"
change_in_percent="+0.44%"
close="15.94"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.18"
high_52_weeks="19.50"
last_trade_date="2/1/2017"
last_trade_price="15.94"
last_trade_size="4031"
last_trade_time="4:00pm"
low="15.68"
low_52_weeks="12.02"
market_capitalization="350.39M"
moving_average_200_day="15.50"
moving_average_50_day="16.63"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.67"
open="15.97"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+2.81%"
percent_change_from_50_day_moving_average="-4.15%"
percent_change_from_52_week_high="-18.26%"
percent_change_from_52_week_low="+32.61%"
previous_close="15.87"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.42"
price_per_sales="329.42"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="18.93"
stock_exchange="NGM"
symbol="ADMS"
volume="147628"
weeks_range_52="12.02 - 19.50"
